Corbus Pharmaceuticals (0SZI.LSE) Q3 2024 Earnings

6AugConfirmed
Q4 2023
Q2 2024
Q3 2024
-2.16
-1.71
-1.27
-0.83

Details

Expected EPS
-1.187967
Actual EPS
-0.9
Surprise EPS
0.29
Surprise Percent
+24.24%

Description

Corbus Pharmaceuticals (0SZI.LSE) has reported earnings of -0.9 per share for Q3 2024.

0 Comments

Share your thoughts